Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study

Endocrine

Volumn 49, Issue 2, 2015, Pages 503-511

  Lubrano, Carla ^a   Tenuta, Marta ^a   Costantini, Daniela ^a   Specchia, Palma ^a   Barbaro, Giuseppe ^a   Basciani, Sabrina ^a   Mariani, Stefania ^a   Pontecorvi, Alfredo ^b   Lenzi, Andrea ^a   Gnessi, Lucio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Empty sella; Growth hormone deficiency; Magnetic resonance imaging; Obesity; Pituitary

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY MASS; BONE DENSITY; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMPTY SELLA SYNDROME; FAT MASS; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEART LEFT VENTRICLE MASS; HUMAN; HYPOPHYSIS ADENOMA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTPATIENT CARE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; COMORBIDITY; DEFICIENCY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMPTY SELLA SYNDROME; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OBESITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84929956787     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0530-0     Document Type: Article

References (42)

1. C. Lubrano, G. Genovesi, P. Specchia, D. Costantini, S. Mariani et al., Obesity and metabolic comorbidities: environmental diseases? Oxid. Med. Cell. Longev (2013). doi:10.1155/2013/640673
2. J. Weaver, Classical endocrine diseases causing obesity. Front Horm. Res. 36, 212–228 (2008). doi:10.1159/00001153678
3. G.J. Morton, D.E. Cummings, D.G. Baskin, G.S. Barsh, Schwartz MW central nervous system control of food intake and body weight. Nature 443, 289–295 (2006)
4. J.P. Thaler, C.X. Yi, E.A. Schur, S.J. Guyenet, B.H. Hwang et al., Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153–162 (2012). doi:10.1172/JCI59660
5. L. De Marinis, S. Bonadonna, A. Bianchi, G. Maira, Giustina A primary empty sella. J. Clin. Endocrinol. Metab. 90, 5471–5477 (2005)
6. A. Giustina, G. Aimaretti, M. Bondanelli, F. Buzi, S. Cannavò et al., Primary empty sella: why and when to investigate hypothalamic-pituitary function. J. Endocrinol. Invest. 33, 343–346 (2010)
7. I.W. Seetho, Wilding JP How to approach endocrine assessment in severe obesity? Clin. Endocrinol. 79, 163–167 (2013). doi:10.1111/cen.12256
8. K.K. Ho, GH deficiency consensus workshop participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur. J. Endocrinol. 157, 695–700 (2007)
9. M.E. Molitch, D.R. Clemmons, S. Malozowski, G.R. Merriam, Vance ML evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1587–1609 (2011). doi:10.1210/jc.2011-0179
10. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher et al., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)
11. G. Corneli, C. Di Somma, R. Baldelli, S. Rovere, V. Gasco, The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur. J. Endocrinol. 153, 257–264 (2005)
12. K.R. Krishnan, P.M. Doraiswamy, S.N. Lurie, G.S. Figiel, M.M. Husain et al., Pituitary size in depression. J. Clin. Endocrinol. Metab. 72, 256–259 (1991)
13. A.D. Elster, Modern imaging of the pituitary. Radiology 187, 1–14 (1993)
14. S. Migliaccio, G. Barbaro, R. Fornari, G. Di Lorenzo, M. Celli, C. Lubrano et al., Impairment of diastolic function in adult patients affected by osteogenesis imperfecta clinically asymptomatic for cardiac disease: casuality or casuality? Int. J. Cardiol. 131, 200–203 (2009)
15. S. Mariani, D. Fiore, G. Barbaro, S. Basciani, M. Saponara et al., Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. Int. J. Cardiol. 167, 2244–2249 (2013). doi:10.1016/j.ijcard.2012.06.011
16. L. M. Donini, E. Poggiogalle, V. Del Balzo, C. Lubrano, M. Faliva, et al. How to estimate fat mass in overweight and obese subjects. Int. J. Endocrinol. (2013) doi:10.1155/2013/285680
17. M. Maghnie, A. Lindberg, M. Koltowska-Häggström, M.B. Ranke, Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database). Eur. J. Endocrinol. 168, 211–217 (2013)
18. A.Y. Kargi, G.R. Merriam, Diagnosis and treatment of growth hormone deficiency in adults. Nat. Rev. Endocrinol. 9, 335–345 (2013)
19. V.E. Chaves, F.M. Júnior, Bertolini GL The metabolic effects of growth hormone in adipose tissue. Endocrine 44, 293–302 (2013)
20. C. Di Somma, A. Ciresi, M.C. Amato, S. Savastano, M.C. Savanelli et al., Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index. Endocrine (2014). doi:10.1007/s12020-014-0471-z
21. K.G. Alberti, P. Zimmet, J. Shaw, The metabolic syndrome–a new worldwide definition. Lancet 366, 1059–1062 (2005)
22. D.E. Berryman, C.A. Glad, E.O. List, G. Johannsson, The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat. Rev. Endocrinol. 9, 346–356 (2013)
23. K. Stochholm, C.H. Gravholt, T. Laursen, J.O. Jørgensen, P. Laurberg et al., Incidence of GH deficiency-a nationwide study. Eur. J. Endocrinol. 155, 61–71 (2006)
24. H. Makimura, T. Stanley, D. Mun, S.M. You, S. Grinspoon, The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J. Clin. Endocrinol. Metab. 93, 4254–4260 (2008)
25. M.R. Sage, P.C. Blumbergs, Primary empty sella turcica: a radiological anatomical correlation. Australas. Radiol. 44, 341–348 (2000)
26. H.J. Schneider, G. Aimaretti, I. Kreitschmann-Andermahr, G.K. Stalla, E. Ghigo, Hypopituitarism. Lancet 369, 1461–1470 (2007)
27. M. Gasperi, G. Aimaretti, E. Cecconi, A. Colao, C. Di Somma et al., Impairment of GH secretion in adults with primary empty sella. J. Endocrinol. Invest. 25, 329–333 (2002)
28. Q.G. D’Alessandris, N. Montano, F. Bianchi, F. Doglietto, E. Fernandez et al., Persistence of primary empty sella syndrome despite obesity surgery: report of two unusual cases. Br. J. Neurosurg. 26, 875–876 (2012). doi:10.3109/02688697.2012.697215
29. S. Melmed, Idiopathic adult growth hormone deficiency. J. Clin. Endocrinol. Metab. 98, 2187–2197 (2013)
30. C. Lubrano, M. Saponara, G. Barbaro, P. Specchia, E. Addessi et al., Relationships between body fat distribution, epicardial fat and obstructive sleep apnea in obese patients with and without metabolic syndrome. PLoS ONE 7, e47059 (2012). doi:10.1371/journal.pone.0047059
31. R.J. Brummer, B.A. Bengtsson, The effects of growth hormone on body composition. Asia Pac. J. Clin. Nutr. 4, 151–155 (1995)
32. E.A. Greco, R. Fornari, F. Rossi, V. Santiemma, G. Prossomariti et al., Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int. J. Clin. Pract. 64, 817–820 (2010)
33. M.A. Bredella, M. Torriani, B.J. Thomas et al., Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J. Clin. Endocrinol. Metab. 94, 3995–4002 (2009)
34. A.E. Malavazos, G. Di Leo, F. Secchi, E.N. Lupo, G. Dogliotti et al., Relation of echocardiographic epicardial fat thickness and myocardial fat. Am. J. Cardiol. 105, 1831–1835 (2010). doi:10.1016/j.amjcard.2010.01.368
35. J.G. O’Driscoll, D.J. Green, M. Ireland, D. Kerr, R.I. Larbalestier, Treatment of end-stage cardiac failure with growth hormone. Lancet 349, 1068 (1997)
36. D.L. Roman, E.R. Bobillo, Reversing idiopathic dilated cardiomyopathy with growth hormone: is this possible? Ann. Intern. Med. 126, 834 (1997)
37. A. Frustaci, N. Gentiloni, M.A. Russo, Growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 335, 672–673 (1996)
38. E. Ferrante, A.E. Malavazos, C. Giavoli, F. Ermetici, C. Coman et al., Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency. Nutr. Metab. Cardiovasc. Dis. 23, 459–465 (2013)
39. G. Lombardi, C. Di Somma, L.F. Grasso, M.C. Savanelli, A. Colao et al., The cardiovascular system in growth hormone excess and growth hormone deficiency. J. Endocrinol. Invest. 35, 1021–1029 (2012). doi:10.3275/8717
40. A. Colao, The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol. (Oxf) 69, 347–358 (2008). doi:10.1111/j.1365-2265.2008.03292
41. A. Colao, C. Di Somma, S. Savastano, F. Rota, M.C. Savanelli et al., A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. J. Clin. Endocrinol. Metab. 94, 4414–4422 (2009)
42. K. Stochholm, A. Berglund, S. Juul, C.H. Gravholt, J.S. Christiansen, Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 99, 4141–4148 (2014)